首页> 外文期刊>Obstetrics, gynaecology and reproductive medicine >The science and ethics of human admixed embryos
【24h】

The science and ethics of human admixed embryos

机译:人类混合胚胎的科学与伦理

获取原文
获取原文并翻译 | 示例
           

摘要

Human admixed embryos contain various combinations of animal and human material but are nevertheless predominantly human. A new Human Fertilisation and Embryology Bill is due to come into force in October 2009 that will make provisions for research using four categories of human admixed embryos: cytoplasmic hybrids, true hybrids, transgenic embryos and chimeric embryos. The science underpinning this research relates to nuclear reprogramming and embryonic stem cell technology amongst others. The information gathered holds great promise for providing in-depth understanding of the molecular basis of disease as well as opening the door for exciting new therapeutic options. However, the use of such embryos has ignited public debate and raises contentious ethical issues. Here we outline some of the fundamental aspects of embryonic stem cell technology and the contribution of human admixed embryos to this and allied scientific endeavours. We also discuss the current regulatory climate in the UK and explore some of the ethical concerns raised by research on human admixed embryos.
机译:人类混合的胚胎包含动物和人类材料的各种组合,但仍然主要是人类。新的《人类受精和胚胎学法案》将于2009年10月生效,该法案将为使用人类混合胚胎的四类进行研究提供准备:细胞质杂种,真杂种,转基因胚胎和嵌合胚胎。这项研究的基础科学涉及核重编程和胚胎干细胞技术等。所收集的信息对深入了解疾病的分子基础以及为激动人心的新治疗选择打开大门具有广阔的前景。但是,使用此类胚胎引发了公众辩论,并引发了有争议的道德问题。在这里,我们概述了胚胎干细胞技术的一些基本方面,以及人类混合胚胎对这项和相关科学工作的贡献。我们还将讨论英国目前的监管环境,并探讨人类混合胚胎研究引起的一些伦理关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号